GemVax&KAEL Co.,Ltd. (KOSDAQ:082270)
South Korea flag South Korea · Delayed Price · Currency is KRW
25,050
+50 (0.20%)
Apr 29, 2026, 2:10 PM KST

GemVax&KAEL Revenue

In the year 2025, GemVax&KAEL had annual revenue of 81.53B KRW with 30.05% growth. GemVax&KAEL had revenue of 26.16B in the quarter ending December 31, 2025, with 43.18% growth.

Revenue
81.53B
Revenue Growth
+30.05%
P/S Ratio
13.48
Revenue / Employee
447.97M
Employees
182
Market Cap
1,098.87B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202581.53B18.84B30.05%
Dec 31, 202462.69B-9.52B-13.18%
Dec 31, 202372.21B-3.60B-4.74%
Dec 31, 202275.80B15.43B25.56%
Dec 31, 202160.37B-5.29B-8.06%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MNC Solution Co.,Ltd 266.42B
SFA Engineering 1,630.95B
Fine Semitech 280.26B
Creative & Innovative System 407.18B
Neuromeka 18.95B
Hyulim ROBOT 168.30B
Robostar 75.74B
Hy-Lok 214.57B
Revenue Rankings